Related Experiment Video

Updated: May 28, 2026

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
09:43

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Published on: June 8, 2022

Cutting edge: Calcium/Calmodulin-dependent protein kinase type IV is essential for mesangial cell proliferation and

Kunihiro Ichinose1, Thomas Rauen, Yuang-Taung Juang

  • 1Division of Rheumatology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.

Journal of Immunology (Baltimore, Md. : 1950)
|October 28, 2011
PubMed

Insights

This study identifies calcium/calmodulin-dependent protein kinase type IV as a key factor in lupus nephritis progression. Targeting this kinase offers a promising therapeutic strategy for reducing kidney damage in systemic lupus erythematosus patients.

Area of Science:

  • Immunology
  • Nephrology
  • Molecular Biology

Background:

  • Renal involvement in systemic lupus erythematosus (SLE) significantly increases morbidity and mortality.
  • The precise mechanisms linking systemic immune factors to local kidney damage in lupus nephritis are not fully understood.

Purpose of the Study:

  • To investigate the role of calcium/calmodulin-dependent protein kinase type IV (CaMKIV) in the pathogenesis of lupus nephritis.
  • To explore CaMKIV as a potential therapeutic target for kidney damage in SLE.

Main Methods:

  • Utilized genetic-deletion and pharmacological-inhibition techniques in experimental models.
  • Assessed the impact of CaMKIV on mesangial cell proliferation and cytokine production (IL-6).

Main Results:

  • CaMKIV was found to control spontaneous and PDGF-stimulated mesangial cell proliferation.
  • CaMKIV promotes Interleukin-6 (IL-6) production via AP-1 activation.
  • CaMKIV contributes to altered cytokine profiles observed in SLE patients.

Conclusions:

  • Calcium/calmodulin-dependent protein kinase type IV is identified as a critical mediator of local kidney damage in lupus nephritis.
  • Targeting CaMKIV presents a promising therapeutic avenue to enhance clinical benefit and limit toxicity in lupus nephritis treatment.

More Related Videos

Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection10:15

Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection

Published on: November 10, 2021

The bm12 Inducible Model of Systemic Lupus Erythematosus (SLE) in C57BL/6 Mice12:04

The bm12 Inducible Model of Systemic Lupus Erythematosus (SLE) in C57BL/6 Mice

Published on: November 1, 2015

Related Concept Videos

Type IV Collagen of Basal Lamina01:05

Type IV Collagen of Basal Lamina

Type IV collagen is a 400 nm long, network-forming collagen that acts as a barrier between the epithelial and endothelial cells. Type IV collagen  forms the backbone of the basement membrane by scaffolding with laminin, entactin, proteoglycans, and fibronectin. Apart from rendering structural support to the basement membrane, it also helps entail signaling potentials necessary for both pathological and physiological functions.
A type IV collagen molecule has six alpha chains which can exist in...
Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...